4.3 Article

SLCO1B1*15 allele is associated with methotrexate-induced nausea in pediatric patients with inflammatory bowel disease

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Rheumatology

SLCO1B1variants as predictors of methotrexate-related toxicity in children with juvenile idiopathic arthritis

J. Roszkiewicz et al.

Summary: The study found that the rs4149056 variant in the SLCO1B1 gene is significantly associated with gastrointestinal side effects during MTX therapy, and patients with the rs4149056 TT genotype are more likely to develop hepatotoxicity.

SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2021)

Article Pediatrics

Single nucleotide polymorphisms associated with methotrexate-induced nausea in juvenile idiopathic arthritis

Nini Kyvsgaard et al.

Summary: The study revealed that genetic polymorphisms in a MTX metabolizing enzyme may influence MTX-induced nausea in children with juvenile idiopathic arthritis (JIA). Further research with larger cohorts is needed to fully understand the impact of these SNPs on MTX-induced nausea in JIA.

PEDIATRIC RHEUMATOLOGY (2021)

Review Medicine, General & Internal

Pathophysiology of Inflammatory Bowel Diseases

John T. Chang

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Pharmacology & Pharmacy

Impact of SLCO1B1 Genotype on Pediatric Simvastatin Acid Pharmacokinetics

Jonathan B. Wagner et al.

JOURNAL OF CLINICAL PHARMACOLOGY (2018)

Article Rheumatology

Oral to subcutaneous methotrexate dose-conversion strategy in the treatment of rheumatoid arthritis

Michael H. Schiff et al.

RHEUMATOLOGY INTERNATIONAL (2017)

Article Gastroenterology & Hepatology

Prevalence and Risk Factors for Symptoms of Methotrexate Intolerance in Pediatric Inflammatory Bowel Disease

Claire Dupont-Lucas et al.

INFLAMMATORY BOWEL DISEASES (2017)

Review Pediatrics

Methotrexate-induced nausea in the treatment of juvenile idiopathic arthritis

Sonja Falvey et al.

PEDIATRIC RHEUMATOLOGY (2017)

Review Gastroenterology & Hepatology

Use of Methotrexate in the Treatment of Inflammatory Bowel Diseases

Hans H. Herfarth et al.

INFLAMMATORY BOWEL DISEASES (2016)

Article Gastroenterology & Hepatology

Optimal Doses of Methotrexate Combined with Anti-TNF Therapy to Maintain Clinical Remission in Inflammatory Bowel Disease

Ruben J. Colman et al.

JOURNAL OF CROHNS & COLITIS (2015)

Article Hematology

Genome-wide study of methotrexate clearance replicates SLCO1B1

Laura B. Ramsey et al.

Article Biochemistry & Molecular Biology

Rare versus common variants in pharmacogenetics: SLCO1B1 variation and methotrexate disposition

Laura B. Ramsey et al.

GENOME RESEARCH (2012)

Article Gastroenterology & Hepatology

Short-course Ondansetron for the Prevention of Methotrexate-induced Nausea in Children With Crohn Disease

Anna Kempinska et al.

JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2011)

Review Genetics & Heredity

The influence of SLCO1B1 (OATP1B1) gene polymorphisms on response to statin therapy

S. P. R. Romaine et al.

PHARMACOGENOMICS JOURNAL (2010)

Article Medical Laboratory Technology

Severe toxicities after irinotecan-based chemotherapy in a patient with lung cancer: A homozygote for the SLCO1B1*15 allele

Hiroshi Takane et al.

THERAPEUTIC DRUG MONITORING (2007)